[ ]   [ ]   [ ]                        [ ]      [ ]   [ ]

Are they married yet? YES THEY ARE! - triskele - Jul 12, 2025 - 6:39am
 
NYTimes Connections - Coaxial - Jul 12, 2025 - 6:12am
 
Wordle - daily game - Coaxial - Jul 12, 2025 - 6:07am
 
Beyond mix - jarro - Jul 12, 2025 - 4:25am
 
NY Times Strands - geoff_morphini - Jul 11, 2025 - 9:50pm
 
A motivational quote - steeler - Jul 11, 2025 - 6:58pm
 
Beyond... - GeneP59 - Jul 11, 2025 - 6:35pm
 
Radio Paradise Comments - GeneP59 - Jul 11, 2025 - 6:06pm
 
The Marie Antoinette Moment... - GeneP59 - Jul 11, 2025 - 5:47pm
 
M.A.G.A. - R_P - Jul 11, 2025 - 4:36pm
 
July 2025 Photo Theme - Stone - KurtfromLaQuinta - Jul 11, 2025 - 3:44pm
 
Trump - bobrk - Jul 11, 2025 - 2:47pm
 
Democratic Party - Isabeau - Jul 11, 2025 - 1:52pm
 
Protest Songs - R_P - Jul 11, 2025 - 12:38pm
 
True Confessions - oldviolin - Jul 11, 2025 - 11:56am
 
USA! USA! USA! - R_P - Jul 11, 2025 - 11:40am
 
Jess Roden - legendary UK vocalist - and "Seven Windows" ... - J_C - Jul 11, 2025 - 11:22am
 
• • • The Once-a-Day • • •  - oldviolin - Jul 11, 2025 - 10:47am
 
What the hell OV? - oldviolin - Jul 11, 2025 - 10:34am
 
Great Old Songs You Rarely Hear Anymore - chieromancer1 - Jul 11, 2025 - 10:34am
 
Live Music - oldviolin - Jul 11, 2025 - 10:13am
 
Bug Reports & Feature Requests - Coaxial - Jul 11, 2025 - 10:01am
 
Today in History - Red_Dragon - Jul 11, 2025 - 8:04am
 
It seemed like a good idea at the time - ptooey - Jul 11, 2025 - 6:10am
 
Country Up The Bumpkin - KurtfromLaQuinta - Jul 10, 2025 - 9:13pm
 
TV shows you watch - R_P - Jul 10, 2025 - 5:31pm
 
Wasted Money - GeneP59 - Jul 10, 2025 - 5:22pm
 
Baseball, anyone? - kcar - Jul 10, 2025 - 5:06pm
 
Rock mix / repitition - walk2k - Jul 10, 2025 - 4:31pm
 
Name My Band - GeneP59 - Jul 10, 2025 - 3:24pm
 
How's the weather? - GeneP59 - Jul 10, 2025 - 3:21pm
 
Climate Change - R_P - Jul 10, 2025 - 12:52pm
 
Israel - R_P - Jul 10, 2025 - 11:55am
 
Random Solutions - Random Advice - oldviolin - Jul 10, 2025 - 10:11am
 
Spambags on RP - KurtfromLaQuinta - Jul 10, 2025 - 9:02am
 
misheard lyrics - GeneP59 - Jul 10, 2025 - 6:30am
 
New Song Submissions system - Teja - Jul 10, 2025 - 3:36am
 
TEXAS - Red_Dragon - Jul 9, 2025 - 5:57pm
 
DQ (as in 'Daily Quote') - black321 - Jul 9, 2025 - 11:33am
 
Fascism In America - ColdMiser - Jul 9, 2025 - 10:23am
 
Republican Party - Red_Dragon - Jul 9, 2025 - 7:50am
 
Economix - oldviolin - Jul 9, 2025 - 7:45am
 
Outstanding Covers - oldviolin - Jul 8, 2025 - 9:29pm
 
Trump Lies™ - R_P - Jul 8, 2025 - 7:14pm
 
Musky Mythology - R_P - Jul 8, 2025 - 5:43pm
 
Photography Forum - Your Own Photos - Alchemist - Jul 8, 2025 - 11:45am
 
What is the meaning of this? - islander - Jul 8, 2025 - 10:11am
 
Love & Hate - oldviolin - Jul 8, 2025 - 8:15am
 
Artificial Intelligence - Red_Dragon - Jul 8, 2025 - 6:45am
 
Anti-War - R_P - Jul 7, 2025 - 6:45pm
 
Environment - R_P - Jul 7, 2025 - 5:38pm
 
(Big) Media Watch - R_P - Jul 7, 2025 - 12:04pm
 
The Grateful Dead - black321 - Jul 7, 2025 - 11:17am
 
Music Videos - black321 - Jul 7, 2025 - 9:00am
 
Mixtape Culture Club - KurtfromLaQuinta - Jul 7, 2025 - 8:59am
 
Immigration - black321 - Jul 7, 2025 - 8:02am
 
Russia - Red_Dragon - Jul 7, 2025 - 7:39am
 
Triskele and The Grateful Dead - geoff_morphini - Jul 6, 2025 - 10:33pm
 
Hey Baby, It's The 4th O' July - GeneP59 - Jul 6, 2025 - 9:42pm
 
Customize a shirt with my favorite album - 2644364236 - Jul 6, 2025 - 7:20pm
 
Those Lovable Policemen - R_P - Jul 6, 2025 - 10:56am
 
Beer - SeriousLee - Jul 6, 2025 - 6:54am
 
Iran - R_P - Jul 5, 2025 - 9:01pm
 
What are you doing RIGHT NOW? - Coaxial - Jul 5, 2025 - 6:48pm
 
New vs Old RP App (Android) - mhamann123 - Jul 5, 2025 - 5:41am
 
Britain - R_P - Jul 4, 2025 - 1:41pm
 
Ukraine - R_P - Jul 4, 2025 - 11:10am
 
Best Song Comments. - 2644364236 - Jul 3, 2025 - 11:32pm
 
The Obituary Page - ScottFromWyoming - Jul 3, 2025 - 11:27am
 
Documentaries - Proclivities - Jul 3, 2025 - 9:31am
 
Annoying stuff. not things that piss you off, just annoyi... - Steely_D - Jul 3, 2025 - 8:36am
 
Copyright and theft - black321 - Jul 3, 2025 - 6:48am
 
Fox Spews - islander - Jul 2, 2025 - 10:39am
 
New Music - ScottFromWyoming - Jul 2, 2025 - 7:30am
 
Carmen to Stones - KurtfromLaQuinta - Jul 1, 2025 - 7:44pm
 
Index » Radio Paradise/General » General Discussion » XPRIZE & Singularity University Page: 1, 2, 3  Next
Post to this Topic
miamizsun

miamizsun Avatar

Location: (3283.1 Miles SE of RP)
Gender: Male


Posted: Aug 17, 2022 - 8:41am

didn't see an AI thread so this will have to do for now...




edit: full version


miamizsun

miamizsun Avatar

Location: (3283.1 Miles SE of RP)
Gender: Male


Posted: May 31, 2019 - 3:15pm


miamizsun

miamizsun Avatar

Location: (3283.1 Miles SE of RP)
Gender: Male


Posted: Mar 12, 2019 - 6:12am

sort of the euro-version of singularity u 

Hello Tomorrow

We are a global non-profit on a mission to unlock the potential of deep technologies to solve the world's toughest challenges, by highlighting, empowering and connecting the most promising deeptech entrepreneurs across the globe with the right enablers.






black321

black321 Avatar

Location: An earth without maps
Gender: Male


Posted: Jan 25, 2019 - 9:59am



 miamizsun wrote:
busy day ahead, but i'd like to leave you with something good to snack on


 

I'll see your exponential tech, and raise you one big brother:

https://www.wired.com/story/is...
miamizsun

miamizsun Avatar

Location: (3283.1 Miles SE of RP)
Gender: Male


Posted: Jan 25, 2019 - 4:21am

busy day ahead, but i'd like to leave you with something good to snack on


miamizsun

miamizsun Avatar

Location: (3283.1 Miles SE of RP)
Gender: Male


Posted: Sep 16, 2018 - 8:16am



an awesome display of people using technology to solve the biggest problems we have today (and in the future)  

this is much watch stuff (esp the energy presentation with ramez naam)

enjoy  










miamizsun

miamizsun Avatar

Location: (3283.1 Miles SE of RP)
Gender: Male


Posted: Aug 21, 2018 - 3:48pm

Landmark FDA Approval Brings Powerful Gene Silencing Method to Market

Earlier this month, the FDA approved an entirely new family of drugs, one so powerful that it could put CRISPR-based gene therapy to shame. Backed by two decades of research and a Nobel Prize, these drugs have the ability to cure inherited diseases—and do so without actually needing to edit the delicate genome.

The green-lit therapy is patisiran, a drug ten years in the making by the Cambridge-based Alnylam for genetic nerve damage. But in this rare case, the nature of the drug is perhaps more significant: patisiran is based on a technology called RNA interference, or RNAi, which allows doctors to silence genes that aren’t properly functioning.

Patisiran is just the tip of the iceberg. In theory, RNAi has the potential to cure any disease caused by “bad” proteins, such as stroke, Alzheimer’s, high cholesterol, or other neurodegenerative disorders. The potential is so grand that scientists have long dubbed the technology a way to “drug the undruggable.”

“This approval is part of a broader wave of advances that allow us to treat disease by actually targeting the root cause, enabling us to arrest or reverse a condition, rather than only being able to slow its progression or treat its symptoms,” said FDA commissioner Scott Gottlieb in a press release. “New technologies like RNA inhibitors, that alter the genetic drivers of a disease, have the potential to transform medicine, so we can better confront and even cure debilitating illnesses.”

With other RNA-based therapies hurtling down the drug development pipeline, it’s likely we’ll be seeing more of these drugs soon. Here’s what you need to know.
more


miamizsun

miamizsun Avatar

Location: (3283.1 Miles SE of RP)
Gender: Male


Posted: Aug 21, 2018 - 1:46pm

i'm fairly certain that anyone can sign up and livestream this summit

line up of speakers/presenters here

e
njoy
miamizsun

miamizsun Avatar

Location: (3283.1 Miles SE of RP)
Gender: Male


Posted: Aug 17, 2018 - 6:33am

 islander wrote:

{#Ask}  

So when do we get to trial run the set?

 
when is now a good time?    {#Cheers}

miamizsun

miamizsun Avatar

Location: (3283.1 Miles SE of RP)
Gender: Male


Posted: Aug 17, 2018 - 6:23am



Proclivities

Proclivities Avatar

Location: Paris of the Piedmont
Gender: Male


Posted: Aug 7, 2018 - 9:21am

 miamizsun wrote:

thanks! {#Wave}

i've been crazy busy with some "other" stuff

upgrading my solutions capability and whatnot

or at least that's how i'm trying to rationalize it

{#Biggrin}
 
Good to see you; your secret is safe.
spy smasher
islander

islander Avatar

Location: West coast somewhere
Gender: Male


Posted: Aug 7, 2018 - 9:03am

 miamizsun wrote:

thanks! {#Wave}

i've been crazy busy with some "other" stuff

upgrading my solutions capability and whatnot

or at least that's how i'm trying to rationalize it

{#Biggrin}
 
{#Ask}  

So when do we get to trial run the set?


miamizsun

miamizsun Avatar

Location: (3283.1 Miles SE of RP)
Gender: Male


Posted: Aug 7, 2018 - 8:37am

 NoEnzLefttoSplit wrote:

Good to see you back J!

 

 
thanks! {#Wave}

i've been crazy busy with some "other" stuff

upgrading my solutions capability and whatnot

or at least that's how i'm trying to rationalize it

{#Biggrin}

NoEnzLefttoSplit

NoEnzLefttoSplit Avatar

Gender: Male


Posted: Aug 7, 2018 - 8:18am

 miamizsun wrote:
from last october (i think there's an updated version of this video)
 

 
Good to see you back J!

 
miamizsun

miamizsun Avatar

Location: (3283.1 Miles SE of RP)
Gender: Male


Posted: Aug 6, 2018 - 2:47pm

from last october (i think there's an updated version of this video)


 


miamizsun

miamizsun Avatar

Location: (3283.1 Miles SE of RP)
Gender: Male


Posted: May 22, 2018 - 4:12am

we need people with vision swinging for the fence...


miamizsun

miamizsun Avatar

Location: (3283.1 Miles SE of RP)
Gender: Male


Posted: Apr 9, 2018 - 1:46pm


see more here
miamizsun

miamizsun Avatar

Location: (3283.1 Miles SE of RP)
Gender: Male


Posted: Jan 16, 2018 - 4:23am

Gene Therapy Had a Breakthrough 2017—2018 May Be Even Better

Gene therapy had a hell of a 2017. After decades of promises but failed deliveries, last year saw the field hitting a series of astonishing home runs.

The concept of gene therapy is elegant: like computer bugs, faulty letters in the human genome can be edited and replaced with healthy ones.

But despite early enthusiasm, the field has suffered one setback after another. At the turn of the century, the death of an 18-year-old patient with inherited liver disease after an experimental gene therapy treatment put the entire field into a deep freeze.

But no more. Last year marked the birth of gene therapy 2.0, in which the experimental dream finally became a clinical reality. Here’s how the tech grew into its explosive potential—and a sneak peek at what’s on the horizon for 2018.

1. Bad Blood, Meet CAR-T

It sounds like magic: you harvest a patient’s own immune cells, dose them with an injection of extra genetic material, and turn them into living cancer-hunting machines.

But in 2017, the FDA approved a double whammy of CAR-T immunotherapies. The first, green-lighted in August, helps kids and young adults battle an especially nasty form of leukemia called B-cell acute lymphoblastic leukemia. Two months later, a therapy for adults with non-Hodgkin lymphoma hit the scene.

Together, these approvals marked the long-anticipated debut of gene therapy in the US market. Previously, Europe has led the charge with its approval of Glybera in 2015, a gene therapy that reduces fatty acid buildup in the bloodstream.

The historic nod of confidence for CAR-T has already sparked widespread interest among academics and drug companies alike at finding new targets for the upgraded immune cells (the “T” in “CAR-T” stands for T-cell, a type of immune cell). CAR-T is especially exciting for the cancer field because it helps people who don’t respond to other classic treatments, such as chemotherapy.

Already in the works are treatments that target multiple myeloma, which causes multiple tumors in the bone or soft tissue, and glioblastoma, an aggressive brain tumor for which there is no cure.

But the technology’s potential is hardly limited to cancer. Last year, a preliminary study in two monkeys showed that genetically engineered stem cells can suppress and even eradicate HIV infections. The study, though small, tantalizingly suggests a whole new way to battle HIV after three decades of fruitless search for a vaccine. With multiple CAR-T therapies going through the pipeline, 2018 may very likely welcome new members onto the gene therapy scene.



more here...




miamizsun

miamizsun Avatar

Location: (3283.1 Miles SE of RP)
Gender: Male


Posted: Jan 11, 2018 - 9:26am

a new cancer xprize...{#Cheers}

The Future of Cancer Treatment Is Personalized and Collaborative

Just a few years ago, microscopes were the primary tool used in cancer diagnoses, but we’ve come a long way since.

“We still look at a microscope, we still look at what organ the cancer started in,” Wender said. “But increasingly we’re looking at the molecular signature. It’s not just the genomics, and it’s not just the genes. It’s also the cellular environment around that cancer. We’re now targeting our therapies to the mutations that are found in that particular cancer.”

Cancer treatments in the past have been largely reactionary, but they don’t need to be. Most cancer is genetic, which means that treatment can be preventative. This is one reason why newer cancer treatment techniques are searching for actionable targets in the specific gene before the cancer develops.

When asked how artificial intelligence and machine learning technologies are reshaping clinical trials, Wender acknowledged that how clinical trials have been run in the past won’t work moving forward.

“Our traditional ways of learning about cancer were by finding a particular cancer type and conducting a long clinical trial that took a number of years enrolling patients from around the country. That is not how we’re going to learn to treat individual patients in the future.”

Instead, Wender emphasized the need for gathering as much data as possible, and from as many individual patients as possible. This data should encompass clinical, pathological, and molecular data and should be gathered from a patient all the way through their final outcome. “Literally every person becomes a clinical trial of one,” Wender said.

For the best cancer treatment and diagnostics, Wender says the answer is to make the process collaborative by pulling in resources from organizations and companies that are both established and emerging.

It’s no surprise to hear that the best solutions come from pairing together uncommon partners to innovate.


miamizsun

miamizsun Avatar

Location: (3283.1 Miles SE of RP)
Gender: Male


Posted: Jan 9, 2018 - 6:43am

it's part of moving forward...

New Research Suggests Immunity to CRISPR Gene Editing Poses a Challenge

The issue arises in how the Cas9 proteins researchers use are manufactured.

The authors of the study noted that the most widely-used versions of the protein are extracted from the bacteria Staphylococcus aureus (S. aureus) and Streptococcus pyogenes (S. pyogenes). In bioengineering, particular bacteria—usually selected for being widely available and easy to cultivate—are often used to synthesize particular proteins. For example, most of our medical insulin is made from genetically modified E. coli. The researchers behind the study questioned whether because S. aureus and S. pyogenes regularly infect humans we might have built up some resistance to their proteins already. The infections they cause, often called strep and staph, are widespread enough that most people can be expected to have been exposed to the bacteria.

The study discovered that in many cases, human immune systems produced T-cells that specifically responded to the Cas9 protein from Staphylococcus aureus. This suggests that attempts at therapeutic use would cause an adaptive immune response that might render the therapy ineffective. Indeed, the authors of the paper wrote that use of these proteins in those who’ve been exposed to this bacteria could be harmful. “It may even result in significant toxicity to patients,” according to Stanford University’s Matthew Porteus, a  senior author of the paper. A paper by Wei Leong Chew suggests, “If left unchecked…it could lead to mortality.”

The authors of the paper wanted to ensure immune issues weren’t overlooked. “Like any new technology, you want to identify potential problems and engineer solutions for them,” according to Porteus. “And I think that’s where we’re at. This is an issue that should be addressed.”

But this is far from the end for CRISPR.


Page: 1, 2, 3  Next